0001437749-19-020744.txt : 20191028 0001437749-19-020744.hdr.sgml : 20191028 20191028162926 ACCESSION NUMBER: 0001437749-19-020744 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190610 FILED AS OF DATE: 20191028 DATE AS OF CHANGE: 20191028 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hall Justin CENTRAL INDEX KEY: 0001663021 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33678 FILM NUMBER: 191173323 MAIL ADDRESS: STREET 1: 5980 HORTON STREET, SUITE 550 CITY: EMERYVILLE STATE: CA ZIP: 94608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovaBay Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001389545 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680454536 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 899-8800 MAIL ADDRESS: STREET 1: 2000 POWELL STREET, SUITE 1150 CITY: EMERYVILLE STATE: CA ZIP: 94608 4/A 1 rdgdoc.xml FORM 4/A X0306 4/A 2019-06-10 2019-06-12 0001389545 NovaBay Pharmaceuticals, Inc. NBY 0001663021 Hall Justin C/O NOVABAY PHARMACEUTICALS, INC. 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 1 Interim President & CEO and GC Common Stock 2019-06-10 4 A 0 47500 2.02 A 50905 D Common Stock 2019-06-10 4 S 0 47500 3.03 D 3405 D Stock Option (right to buy) 2.02 2019-06-10 4 X 0 47500 0 D 2019-05-31 2028-05-31 Common Stock 47500 0 D The amended Form 4 is being filed to show (1) the corresponding acquisition of common stock after the exercise of options in Table I and (2) the immediate sale of common stock after such exercise of options in Table I. /s/ Justin Hall 2019-10-28